Governance

The MRC/BHF CoRE in Advanced Cardiac Therapies began on 1 January 2025, with a duration of 14 years. Funding has been secured for an initial 7 year period. An experienced leadership team are responsible for delivering CoRE research and impact. Day-to-day …

Dr Nicola Haines

As REACT COO Nicola works to ensure that we have the strategic and operational capacity to allow the science to run smoothly while maximising the opportunities to reach our goals and deliver impact on behalf of our funders, partners and publics. In REACT, …

Professor Andy Baker

Andy is BHF Professor of Translational Cardiovascular Sciences and Gustav Born Chair of Vascular Biology at the University of Edinburgh. He has a long standing interest in the understanding of vascular pathophysiology. Andy's laboratory was set up with …

Dr Ian McCracken

As a BHF Immediate Fellow, Ian's research focuses on understanding how coronary blood vessel formation is controlled at the gene-expression level during both development and regeneration. In particular, he is interested in how the embryonic endocardium …

Dr Christopher Toepfer

Chris is Associate Professor of Cardiovascular Science at the University of Oxford and Co-director of the Oxford Organoid Hub. His group is interested in understanding changes in cellular function that are driven by acquired and inherited …